← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phoenix Va Health Care System
Phoenix, AZ
$850,780
Total funding
14
Grants
Funding over time
peak $0 · FY2012–25$1$1$1$0$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$850,780 · 2
VA$0 · 12
By mechanism
R01$675,000 · 1
R29$175,780 · 1
I01$0 · 10
IK1$0 · 1
IK2$0 · 1
Investigators at Phoenix Va Health Care System
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Non-traditional Cardiovascular Risk Factors in DM type 2$225,000
R01 · FY2003 · HL
Non-traditional Cardiovascular Risk Factors in DM type 2$225,000
R01 · FY2004 · HL
Non-traditional Cardiovascular Risk Factors in DM type 2$225,000
R01 · FY2001 · HL
BEHAVIORAL INTERVENTION FOR INSOMNIA IN OLDER ADULTS$71,548
R29 · FY2001 · NR
BEHAVIORAL INTERVENTION FOR INSOMNIA IN OLDER ADULTS$67,764
R29 · FY2000 · NR
BEHAVIORAL INTERVENTION FOR INSOMNIA IN OLDER ADULTS$36,468
R29 · FY2002 · NR
Protective Step Training in People with Multiple Sclerosis$0
IK2 · FY2023 · VA
Nanoliposome-based Treatment of Amyloid Protein (AL) Toxicity$0
I01 · FY2015 · VA
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2023 · VA
MHC class II antigen presentation in melanoma: impact on immune recognition$0
I01 · FY2023 · VA
Discovering Novel Mechanisms and Treatment for Aging-Related Dementia: Probing Medin and Abeta Vasculopathy$0
I01 · FY2023 · VA
Brain injury rehabilitation modality, regulation, & structural plasticity$0
I01 · FY2023 · VA
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2024 · VA
Discovering novel mechanisms for aging-related dementia: probing medin and abeta vasculopathy$0
I01 · FY2017 · VA
MHC class II antigen presentation in melanoma: impact on immune recognition$0
I01 · FY2024 · VA
Brain injury rehabilitation modality, regulation, & structural plasticity$0
I01 · FY2021 · VA
Use of continuous glucose monitoring and long-term diabetes outcomes within the Veteran Affairs Health Care System$0
I01 · FY2025 · VA
Protective Step Training in People with Multiple Sclerosis$0
IK2 · FY2022 · VA
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2022 · VA
Mechanistic role of vascular dysfunction in TBI-mediated cognitive dysfunction$0
I01 · FY2025 · VA